<DOC>
	<DOCNO>NCT01999400</DOCNO>
	<brief_summary>This study design provide data FDA correlate pharmacokinetics local availability medication within gastrointestinal tract . This study support establishment scientifically base standard evaluate drug act locally within gastrointestinal tract . Specific objective study : ( 1 ) quantify plasma concentration mesalamine , agent use treat inflammatory bowel disease , correlate concentration gastrointestinal fluid ; ( 2 ) improve physiologically base model drug absorption intestine . Information study concert vitro dissolution data use evaluate vivo-in vitro correlation ( IVIVC ) concentration plasma intestinal lumen dissolution mesalamine product .</brief_summary>
	<brief_title>Correlation Mesalamine Pharmacokinetics With Local Availability</brief_title>
	<detailed_description />
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Inclusion Criteria 1 . Adults age 18 55 . 2 . Male female voluntarily able give inform consent . 3 . Body mass index ( BMI ) 18.5 35 . Exclusion Criteria 1 . Adults unable consent mentally incapacitate . 2 . Prisoners . 3 . Significant clinical illness within 3 week prior Screening . 4 . Use concomitant medication within 2 week prior receive study drug , include limited prescription drug , herbal dietary supplement , counter medication , vitamin . Oral contraception permit . 5 . History gastrointestinal surgery . 6 . History allergy nonsteroidal antiinflammatory drug ( NSAIDs ) ingredient Asacol , Pentasa , Apriso , Lialda . 7 . History severe allergic disease include drug allergy , exception seasonal allergy . 8 . Any factor , condition , disease , include , limited , cardiovascular , renal , hepatic , gastrointestinal disorder may , opinion Investigator , jeopardize safety patient impact validity study result . 9 . History drug addiction alcohol abuse within past 12 month . 10 . Pregnant lactating female . 11 . Surgery within past 3 month . 12 . Received investigational drug within 60 day prior receive study drug . 13 . Any clinically significant abnormal lab value Screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>